How was the price per share determined for MaryAnn Wright’s BRUNSWICK CORP (BC) grant?

The filing lists a value of $79.45 per share for MaryAnn Wright’s 547-share award. This price represents the per-share value used to record the grant on April 30, 2026, and helps quantify the size of the compensation award.

Brunswick (NYSE: BC) director MaryAnn Wright granted 547 deferred shares

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

BRUNSWICK CORP director MaryAnn Wright received a grant of 547 shares of Common Stock, valued at $79.45 per share, as of April 30, 2026. These are deferred shares deposited into her director deferred account and will be distributed in preset installments after she ceases being a director. Following this award, her beneficial holdings total 11,125 shares, including 67 shares acquired through dividend reinvestment through March 2026.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Wright MaryAnn

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	547	$79.45	$43K

Holdings After Transaction: Common Stock — 11,125 shares (Direct, null)

Footnotes (1)

Deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company. Beneficial holdings include 67 shares acquired pursuant to dividend reinvestment through March 2026

Key Figures

Shares granted: 547 shares Grant price per share: $79.45 per share Total holdings after transaction: 11,125 shares +1 more

4 metrics

Shares granted 547 shares Deferred stock award on April 30, 2026

Grant price per share $79.45 per share Value used for the April 30, 2026 award

Total holdings after transaction 11,125 shares Beneficial ownership following the grant

Dividend reinvestment shares 67 shares Acquired via dividend reinvestment through March 2026

Key Terms

deferred shares, director's deferred account, dividend reinvestment, beneficial holdings

4 terms

deferred shares financial

"Deferred shares deposited in the director's deferred account, which will be automatically distributed"

Deferred shares are a class of stock whose economic benefits or certain shareholder rights are delayed or paid later than ordinary shares—for example, dividends may be paid only after other shareholders receive theirs, or voting or redemption rights may be postponed. For investors, that timing difference matters because deferred shares typically offer lower near-term income and different risk, affecting expected returns, priority in payouts, and the share’s market value; think of them like a delayed paycheck compared with a regular salary.

director's deferred account financial

"deposited in the director's deferred account, which will be automatically distributed"

dividend reinvestment financial

"Beneficial holdings include 67 shares acquired pursuant to dividend reinvestment through March 2026"

Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.

beneficial holdings financial

"Beneficial holdings include 67 shares acquired pursuant to dividend reinvestment"

Form 4 Insider Transactions: What Each Field Means →

05/04/2026 - 11:36 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wright MaryAnn

(Last)

(First)

(Middle)

C/O BRUNSWICK CORPORATION

26125 N. RIVERWOODS BLVD. #500

(Street)

METTAWA

ILLINOIS

60045

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BRUNSWICK CORP [ BC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/30/2026		A		547⁽¹⁾	A	$79.45	11,125⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company.

2. Beneficial holdings include 67 shares acquired pursuant to dividend reinvestment through March 2026

Remarks:

	By: Power of Attorney: /s/MaryAnn Wright	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did BRUNSWICK CORP (BC) director MaryAnn Wright report?

MaryAnn Wright reported receiving 547 shares of Brunswick Common Stock as a grant. The shares were awarded at $79.45 per share and deposited into her director deferred account, increasing her beneficial holdings to 11,125 shares in total.

Were MaryAnn Wright’s new BRUNSWICK CORP (BC) shares an open-market purchase?

No, the 547 shares reported by MaryAnn Wright were a grant, not an open-market purchase. They are classified as deferred shares credited to her director deferred account, to be distributed automatically after she stops serving as a director.

How many BRUNSWICK CORP (BC) shares does MaryAnn Wright hold after this grant?

After the 547-share grant, MaryAnn Wright beneficially holds 11,125 Brunswick shares. This total includes 67 shares that were acquired through dividend reinvestment programs through March 2026, in addition to the newly granted deferred shares.

What are deferred shares in the context of BRUNSWICK CORP (BC) director compensation?

For Brunswick directors, deferred shares are stock awards credited to a deferred account instead of being delivered immediately. MaryAnn Wright’s 547 deferred shares will be automatically distributed in predetermined installments after she ceases serving as a director of the company.